Related Experiment Videos

Erythema multiforme: a possible pathogenetic role of increased reactive oxygen species

Journal of Clinical & Laboratory Immunology
|January 1, 1986
PubMed

Insights

Reactive oxygen species (ROS) from polymorphonuclear leukocytes (PMNs) may cause tissue damage in erythema multiforme (EM). Studies show increased hydroxyl radical production in EM patients, suggesting ROS involvement in lesion formation.

Area of Science:

  • Immunodermatology
  • Oxidative Stress Research

Background:

  • Reactive oxygen species (ROS) from activated polymorphonuclear leukocytes (PMNs) are implicated in inflammatory tissue damage.
  • The specific role of ROS in erythema multiforme (EM) pathogenesis requires further investigation.

Purpose of the Study:

  • To investigate the role of ROS in erythema multiforme (EM) pathogenesis.
  • To determine the capacity of sera from EM patients to generate ROS from PMNs.

Main Methods:

  • Assessing ROS generation by incubating PMNs with sera from EM patients.
  • Comparing ROS production in EM patients versus those with bullous pemphigoid (BP) and inflammatory acne.
  • Measuring C1q activities and detecting immunoreactant depositions.

Main Results:

  • Significantly increased hydroxyl radical production was observed in EM patient sera.
  • This elevated ROS production was specific to EM, not seen in BP or acne patients.
  • Elevated C1q activities and vascular immunoreactant depositions were noted in some EM patients.

Conclusions:

  • ROS generated by PMNs contribute to the pathogenesis of cutaneous lesions in EM.
  • Immune complexes (ICs) may play a crucial role in activating PMNs in EM.
  • These findings highlight a potential mechanism involving oxidative stress and immune complex formation in EM development.

Related Concept Videos